VivoSeq
Other

Ankle Surgery

0

Pipeline Programs

2

Active Trials

0

Companies Involved

Ankle Surgery is an early-stage landscape with 0 programs across 0 companies.

Pipeline Metrics

Competitive Density

10/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

60/100

Attrition Rate

22/100

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

9

clinical trials

Completed3 · 33%
Recruiting2 · 22%
Unknown status2 · 22%
Withdrawn2 · 22%

Trial Activity

9 trials

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)